Publications by authors named "Eva ESSeling"

Claim this Profile
A
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.
Anne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, Katja Sockel, Rebekka Wehner, Eva Esseling

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning.
Lina Kolloch, Philipp Berning, Jörn C Albring, Julian Ronnacker, Christian Reicherts, Eva Esseling

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Melphalan Followed by Busulfan and Fludarabine Conditioning Prior to Allogeneic Stem Cell Transplantation in Elderly Patients with Active Acute Myeloid Leukemia-A Retrospective Single-Center Study.
Julian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, Simon Call, Eva Eßeling

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.
Julian Ronnacker, Michael Grau, Maximilian Klasmeier, Christian Klesse, Henning Baldauf

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.
Philipp Berning, Lina Kolloch, Christian Reicherts, Simon Call, Julia Marx, Eva Esseling

Bone Marrow Transplant· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.
Julian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, Lina Kolloch, Philipp Berning

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Thomas Schroeder, Matthias Stelljes, Maximilian Christopeit, Eva Esseling, Christoph Scheid

Haematologica· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With -Internal Tandem Duplication Mutation (SORMAIN).
Andreas Burchert, Gesine Bug, Lea V Fritz, Jürgen Finke, Matthias Stelljes

J Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma.
Christine Eisfeld, Eva Eßeling, Ramona Wullenkord, Cyrus Khandanpour, Julia Reusch

Ann Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
Klaus Wethmar, Svenja Matern, Eva Eßeling, Linus Angenendt, Heike Pfeifer

Bone Marrow Transplant· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
Ilka Isfort, Magdalene Cyra, Sandra Elges, Sareetha Kailayangiri, Bianca Altvater

Clin Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis